This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The development of serologic tests for antineutrophil cytoplasmic antibodies (ANCA) has enabled a better characterization of the small vessel vasculitides that include Wegener’s granulomatosis, Churg–Strauss syndrome, and microscopic polyangiitis.1 ANCA-associated vasculitides can involve the central and peripheral nervous systems.2 This report summarizes the case of a patient who sought treatment for ischemic optic neuropathy, an unusual complication of these disorders.
Case report.
A 67-year-old man was referred for evaluation of partial loss of vision of the right eye. Symptoms had started suddenly approximately 4 weeks before the examination, and the patient described an area of decreased vision, or “haze,” close to the center of the eye’s visual field. The systems review was positive for occasional blood-tinged sputum of 1-year duration, chronic joint pains, hypertension, and hyperlipidemia. There was no history of fever, weight loss, or jaw claudication. The neurologic examination, including palpation of the preauricular and forehead arteries, was normal. Funduscopic examination showed …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
- ANCA-associated small vessel vasculitis presenting with ischemic optic neuropathy
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis
Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA
Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis
Refractory giant cell arteritis with spinal cord infarction